3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Metabolic Syndrome
1
Lymphoma, Non-Hodgkin
1
Heart Failure
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Cardiomyopathies
1
Interventions
Echocardiography
6
Doxorubicin
3
Carvedilol
3
empagliflozin
2
Social Determinants of Health
2
Electrocardiography
2
Cyclophosphamide
2
pegfilgrastim
1
dapagliflozin
1
Watchful Waiting
1
Vincristine
1
Vascular Stiffness
1
Trastuzumab
1
Tablets
1
Standard of Care
1
Rosuvastatin Calcium
1
Rituximab
1
Resistance Training
1
Pulse Wave Analysis
1
Prednisolone
1
Palliative Care
1
Observation
1
Methods
1
Lenalidomide
1
Hematologic Tests
1
Fenofibrate
1
Exercise Test
1
Environmental Biomarkers
1
EGFR tyrosine kinase inhibitor 324674
1
Dexrazoxane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Pulse Wave Analysis
×
1 year
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled